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INTRODUCTION
  Generally, the acute physiology and chronic health evaluation 
(APACHE) II score is regarded as a precise predictor of the 
mortality rate of severely ill patients and as a guideline for 
active treatment plans for critically ill patients.1) In addition, 
the APACHE II score has been used commonly as a basic re-
search tool for treatment planning of the critically ill patients.
  Because a lower APACHE II score indicates a better prog-
nosis, these patients are more likely to benefit from the impro-
ved patient's management than those with a higher APACHE 
II score. Accordingly, these relatively low risk patients are obvi-
ous targets for decreasing the rate of intensive care unit (ICU) 
mortality. In the view of cost-effectiveness, the APACHE II 
score has played a major role in predicting the patient's prog-
nosis and determining the degree of active treatment.2) So, it 
would be valuable to know the clinical characteristics of pati-
ents who died despite of low APACHE II score after intensive 
care.
  This study investigated the clinical characteristics of those 
patients who died despite having a low APACHE II score af-
ter intensive care. 
MATERIALS AND METHODS
  This study reviewed the medical records of 729 patients, ad-
mitted to the general ICU of the University Hospital from Jun 
1, 2001 to May 31, 2002, whose admission APACHE II sco-
res were 10 or less. 
  The patients were divided in two groups. The expired group 
  Background:  The acute physiology and chronic health evaluation (APACHE) II score is considered to be a precise predictor 
of mortality and a useful basic research tool.  A lower APACHE II score means a better prognosis of patients, which means 
that these relatively low risk patients are more likely to benefit from the improved patient management than the higher predicted 
mortality admissions.  Therefore, these patients are obvious targets for intensive care and for decreasing the level of intensive 
care unit (ICU) mortality.  
  Methods:  This study reviewed the medical records of 729 patients, whose APACHE II scores on the ICU admission day were 
10 or less, from June 1, 2001 to May 31, 2002 in University Hospital.  The data of the patient's age, gender, disease category, 
first admission or readmission, APACHE II score, length of stay at the ICU and the hospital were reviewed.  
  Results:  The average mortality rate of the patients who had an APACHE II score of 10 or less was 4.1%.  The mortality 
of the cancer patients (8%) was significantly higher than the other disease groups.  The mortality of the readmitted patients was 
significantly higher than the mortality of the patients who were admitted to the ICU for the first time.  
  Conclusions:  Among the patients in the ICU with a low APACHE II score, the mortality of cancer patients was high.  The 
mortality of the readmitted patients was significantly higher than in those on the first admission.  (Korean J Anesthesiol 2005; 
48: S 34∼7)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Key Words:  APACHE II score, intensive care unit, mortality. 
Clinical Characteristics of the Patients Who Died Despite of 
Low APACHE II Score after Intensive Care
1Department of Anesthesiology and Pain Medicine, 2Anesthesiology and Pain Research Institute,
Yonsei University College of Medicine, Seoul, Korea
Chul Ho Chang, M.D.1, Kee Young Lee, M.D.1,2, Sang Beom Nam, M.D.1,2, Jin Woo Bae, M.D.1
and Cheung Soo Shin, M.D.1,2
Received：January 16, 2005
Corresponding to：Cheung Soo Shin, Department of Anesthesiology and 
Pain Medicine, Yongdong Severance Hospital, 146-92 Dogok-dong, 
Gangnam-gu, Seoul 135-720, Korea. Tel: 82-2-3497-3522, Fax: 82- 
2-3463-0940, E-mail: Cheungsoo56@yumc.yonsei.ac.kr
 Chul Ho Chang, et al：Clinical Characteristics of Low APACHE II Score
S 35
was comprised of 30 patients who died at the ICU or general 
ward after discharge from the ICU, and the survival group 
comprised of 699 patients who were discharged from the hos-
pital after intensive care. The data on the patients' age, gen-
der, main disease category of patients, APACHE II score upon 
admission to the ICU, the length of stay at the ICU, the leng-
th of stay at the hospital after discharge from the ICU and the 
first admission to the ICU or readmission were reviewed. 
  The data except for age, length of stay at the ICU and 
length of stay at the hospital were analyzed using a Chi-square 
test (for 2 × 2 tables containing a value less than five, Fish-
er's Exact Test). The age, ICU day, hospital day of the two 
groups were compared using a student t-test. A p value ＜ 
0.05 was considered statistically significant. 
RESULTS
  The mortality of the patients who had an APACHE II score 
of 10 or less at the time of ICU admission was 4.1%. The 
mean age of the survival and expired group was 59 and 58 
years, respectively. The number of ICU days of the survival 
and expired group was 2.5 ± 3.9 days and 8.5 ± 12.5 days, 
respectively. Age, gender, the length of stay at the ICU and 
the length of stay at the hospital of the two groups were not 
significantly different (Table 1).
  The main disease of these patients was cardiovascular disease 
(n = 405), cancer (n = 100), gastrointestinal disease (n = 64), 
trauma (n = 45), and respiratory disease (n = 40). In the can-
cer patients 8 out of 100 patients were died, which was a sig-
nificantly higher mortality than with the other diseases (Table 2).
  The number of patients who expired at the ICU, in the gene-
ral ward and those of hopeless discharge was 6, 21 and 3, re-
spectively. Three among the 30 expired patients and 14 patients 
among 699 survival patients were readmission cases (Fig. 1). 
DISCUSSION
  In our hospital, the decision for ICU admission was made 
under the guidelines for intensive care unit admission, dischar-
ge, and triage suggested by the Task Force of the American 
College of Critical Care Medicine, Society of Critical Care 
Medicine.3) This system defines those who will most benefit 
from the ICU (Priority 1) and those who will not benefit at 
Table 1. Demographic Data
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Group Expired Survival
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Sex (M/F) 16/14 447/252
Age (yr)  59.5 ± 18.1 58.5 ± 14.8
LOSICU (d)   8.5 ± 12.5 2.5 ± 3.9
LOSH (d)  32 ± 50 6.4 ± 2.3
APACHE II score  6.4 ± 2.3 p7.8 ± 1.8
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Values are expressed as a mean ± SD. LOSICU: length of stay at 
the intensive care unit, LOSH: length of stay at the hospital.
Table 2. Disease Distribution of Patients
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Group Dead Alive
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
CV 12 393
CA  8*  92
GI  4  60
RES  3  37
TR  1  44
MS  1  19
CON  1  10
END  0  17
INF  0   9
NEU  0   9
OB  0   9
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Total 30 699
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
CV: cardiovascular disease, CA: cancer, GI: gastrointestinal disease, 
RES: respiratory disease, TR: trauma, MS: musculoskeletal disease, 
CON: congenital disease, END: endocrine disease, INF: infectious 
disease, NEU: nervous system disease, OB: obstetric disease. *: P ＜ 
0.05 compared to the other disease groups.
Fig. 1. Mortality of patients admitted for the first time or readmitted 
to the ICU with an APACHE II score 10 or less. *: P ＜ 0.05 
compared with the first admission group.
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all (Priority 4). Patients with a terminal or irreversible illness 
are generally not suitable candidates for ICU admission. It is 
believed that the majority of cancer patients in this study be-
longed to Priority 3 or 4. However, if patients with a me-
tastatic malignancy and an acute infection or pulmonary edema 
are admitted to the ICU to relieve the acute illness, the best 
therapeutic efforts such as intubation and mechanical ventilation 
are usually made to reverse the acute exacerbated condition. 
  In this study one of the major findings is that the mortality 
of the cancer patients was significantly higher than that with 
the other disease.
  Among the patients of low APACHE II score, why the 
mortality of the cancer patients was significantly high can be 
explained as follows:
  First, some investigators have suggested that the duration of 
the physiological derangements can influence on the outcome 
independent of the degree.4) This may be an explanation for 
the illness-severity difference in that cancer patients who are 
admitted hospital for a long time generally have unmeasured 
clinical and laboratory abnormalities.
  Another explanation may be that there might be a desire for 
these patients to be transferred to the ICU. This is despite the 
fact that prior therapy in general ward is a marker for patients 
who are likely to respond poorly to further therapy. In many 
cases, the decision to transfer patients to ICU results from the 
poor response to therapy in a non intensive care setting. Such 
patients are more likely to respond poorly to therapy in an 
ICU and have a higher risk of death. A failure to respond to 
prior therapy has been found to be associated with a poor re-
sponse to a subsequent treatment in another clinical setting.5) 
In addition, all the cancer patients who died were transferred 
to ICU from a general ward.
  Although the mortality rate was not significantly high, cardi-
ovascular disease was the most common in expired group. The 
predictive accuracy of the APACHE II system in cardiovas-
cular disease was relatively poor. This can be explained as 
follows: 
  First, comparing the patient outcomes in intensive care unit 
require an accurate assessment of and an adjustment for co- 
morbid disease. The co-morbid conditions with various diseases 
were AIDS, hepatic failure, lymphoma, solid tumor with a me-
tastasis rather than cardiovascular disease.
  Second, the poor predictive accuracy of the admission score 
can be influenced by this lead time bias, resulting in an un-
derestimation of the mortality in patients with an incorrectly 
low score.4,6) An explanation for these unmeasured illness-seve-
rity differences may be that the therapy, which was received 
prior to admission to the ICU, affects the relationship between 
the physiological abnormalities measured in the intensive care 
unit and patients' risk of death. The APACHE II score that is 
based on the data obtained within 24 hours of transfer to the 
ICU are reasonably independent of the treatment in the ICU, 
but are not independent of the treatment before transfer. This 
means that when patients with acute ischemic heart disease are 
admitted to the ICU via emergency room after stabilizing their 
vital signs, their APACHE II score at the ICU admission time 
might be low.
  Therapy administered to hospital inpatients prior to transfer 
to the ICU could mask the physiological manifestations of 
their severe illness by improving the preexisting clinical and 
laboratory abnormalities more than the underlying disease pro-
cess or by blunting the abnormalities associated with an acute 
condition that necessitated the transfer. This phenomenon is 
called the lead time bias, because it results from measuring 
the APACHE II score not at the time when the therapy is ini-
tiated, but later in the patient's course of medical care when 
the physiological variables have changed in response to treat-
ment.7)
  This study found that the mortality of the readmitted pati-
ents was significantly higher than that of the patients who 
were admitted ICU for the first time. Both the admission and 
discharge criteria of the ICUs are critical issues in the allo-
cation of limited health care resources. Cullen8) and Jennett9) 
examined the ICU admission policies, describing the inappro-
priate utilization of intensive care facilities. Much less empha-
sis has been placed on the discharge criteria. 
  In hospital readmission is a frequent problem. It has been 
previously reported that readmissions have a mortality rate 2-
3 times that of other MICU patients.10) The major reasons for 
the high mortality rate appear to be related to the initial pri-
mary diagnosis and to the severity of their illness upon read-
mission. More than one half of the patients who were dis-
charged and readmitted had a recurrence of their original dis-
ease. Almost 30% of those patients readmitted to the ICU re-
turned due to a complication that was not a direct recurrence 
of the patient's original disease. These complications were gen-
erally not predictable, but ordinary. It is believed that an inter-
mediate care unit might be an effective alternative to an early 
ICU discharge by reducing the likelihood of a premature ICU 
discharge and hence, reducing the number of readmissions to 
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the ICU.
  It is apparent that the effective utilization of the intensive 
care resources depends not only on rational admission policies 
but also on the appropriate discharge policies. 
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